Showing results (1721-1730 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|January 1, 1987
In vitro activity of BMY-28142, a new cephalosporinC W Norden, K NeiderriterChemotherapy|October 13, 2021
S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy RegimensAngelo Onorato, Andrea Napolitano, Silvia Spoto, et al.Chemotherapy|October 28, 2021
Isatuximab plus Pomalidomide and Dexamethasone in a Patient with Dialysis-Dependent Multiple MyelomaTeruhito Takakuwa, Kensuke Ohta, Nobuhiro Sogabe, et al.Chemotherapy|January 1, 1986
Penetration of N-formimidoyl thienamycin into extravascular fluids in rabbitsT Olay, M V Vicente, A RodríguezChemotherapy|January 1, 1986
Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in miceT Fujimoto, M Sato, K Katami, et al.Chemotherapy|January 1, 1987
Influence of dosage interval on the therapeutic response to gentamicin in mice infected with Klebsiella pneumoniaeM L Queiroz, N Bathirunathan, G E MawerChemotherapy|June 6, 2019
Pharmacokinetics of Benzylpenicillin (Penicillin G) during Prolonged Intermittent Renal Replacement TherapyVesa Cheng, Matthew Rawlins, Tim Chang, et al.Chemotherapy|March 20, 2022
Venetoclax in Combination with Hypomethylating Agents for the Treatment of Treatment-Naive B/Myeloid Mixed-Phenotype Acute Leukemia and Relapsed/Refractory Acute Myeloid Leukemia: A Report of 3 CasesNa Wang, Jing He, Fang LiuChemotherapy|October 11, 2018
Pharmacokinetics of Ceftolozane-Tazobactam during Prolonged Intermittent Renal Replacement TherapyMatthew Rawlins, Vesa Cheng, Edward Raby, et al.Chemotherapy|March 6, 2022
Risk of Immune-Related Pneumonitis with PD-1/PD-L1 Inhibitors in Different Cancer Types and Treatment Regimens: A Systematic Review and Meta-Analysis of 22 Randomized Controlled TrialsLei Han, Guangxin Li, Huihui Li, et al.Pageof 308